GRIB participates in the project OPEN PHACTS funded by IMI

The OpenPHACTS consortium comprises 14 European academic institutions and SME partners and 8 pharmaceutical companies. Ferran Sanz leads the participation of the Research Programme on Biomedical Informatics GRIB (IMIM-UPF) in this project. The GRIB will coordinate the project work package that will be in charge of the development of applications for the exploitation of the new knowledge resource in order to afford drug discovery questions.

The OpenPHACTS aim is to develop an enabling knowledge infrastructure for the drug discovery projects on the basis of the semantic web technology operating on information that is freely available in the public domain.

The total budget of the project is 16,5 million euros and is funded by the Innovative Medicines Initiative (IMI), a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Site Information